Clinical trial NCT05714332: Impacts of an Advanced Practice Physiotherapy Model of Care for Adults With a Peripheral Musculoskeletal Disorders Referred to an Orthropaedic Outpatient Clinic
Official title: Impacts of an Advanced Practice Physiotherapy Model of Care for Adults With a Peripheral Musculoskeletal Disorders Referred to an Orthropaedic Outpatient Clinic: a Prospective Observational Study
Study type: OBSERVATIONAL
Overall status: RECRUITING
Conditions: Musculoskeletal Disorders
Keywords: Advanced practice
Physiotherapy
Musculoskeletal disorders
Orthopedic
Observation
Lead sponsor: Ciusss de L'Est de l'Île de Montréal
Sponsor class: OTHER
First posted: 2023-02-06
Enrollment: 152
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Adults with a peripheral musculoskeletal disorders

Brief summary: The goal of this prospective observational study is to evaluate advanced practice physiotherapy and orthopedic surgeon care and clinical outcomes for new patients with a peripheral musculoskeletal disorders consulting at the orthopedic outpatient clinic of the Hôpital Jean-Talon.

The main questions it aims to answer are: 1. To describe the models of care at the Hôpital Jean-Talon orthopedic outpatient clinic; 2. To assess change in pain, disability, quality of life and pain catastrophizing at 6, 12 and 26 weeks after the initial evaluation; 3. To assess interprofessional collaboration between the advanced practice physiotherapists and orthopedic surgeons; 4. To assess patient satisfaction with care; 5. To assess waiting time before an initial consultation.

Researchers will compare patients cared in the advanced practice physiotherapy and orthopedic surgeon group and the orthopedic surgeon only group.


Eligibility criteria: Inclusion Criteria:

* Adults with peripheral musculoskeletal disorders
* New consultation at the Hôpital Jean-Talon orthopedic outpatient clinic
* Legally able to consent
* Understand and speak French or English
* Beneficiaries of the provincial universal health insurance coverage (RAMQ)

Exclusion Criteria:

* Patients directly referred from the emergency department (not considered as patients referred to the outpatient clinic).

Primary outcomes:
measure: Brief pain inventory severity
timeFrame: 6 weeks (change from baseline)
measure: Brief pain inventory severity
timeFrame: 12 weeks (change from baseline)
measure: Brief pain inventory severity
timeFrame: 26 weeks (change from baseline)
measure: Brief pain inventory inventory
timeFrame: 6 weeks (change from baseline)
measure: Brief pain inventory inventory
timeFrame: 12 weeks (change from baseline)
measure: Brief pain inventory inventory
timeFrame: 26 weeks (change from baseline)
Secondary outcomes:
measure: Shortened Disability of the Arm, Shoulder and Hand (QuickDASH)
timeFrame: 6 weeks (change from baseline)
measure: Shortened Disability of the Arm, Shoulder and Hand (QuickDASH)
timeFrame: 12 weeks (change from baseline)
measure: Shortened Disability of the Arm, Shoulder and Hand (QuickDASH)
timeFrame: 26 weeks (change from baseline)
measure: Hip disability and Osteoarthritis Outcomes Score (HOOS)
timeFrame: 6 weeks (change from baseline)
measure: Hip disability and Osteoarthritis Outcomes Score (HOOS)
timeFrame: 12 weeks (change from baseline)
measure: Hip disability and Osteoarthritis Outcomes Score (HOOS)
timeFrame: 26 weeks (change from baseline)
measure: Knee injury and Osteoarthritis Outcomes Score (KOOS)
timeFrame: 6 weeks (change from baseline)
measure: Knee injury and Osteoarthritis Outcomes Score (KOOS)
timeFrame: 12 weeks (change from baseline)
measure: Knee injury and Osteoarthritis Outcomes Score (KOOS)
timeFrame: 26 weeks (change from baseline)
measure: Foot and Ankle Ability Measure (FAAM)
timeFrame: 6 weeks (change from baseline)
measure: Foot and Ankle Ability Measure (FAAM)
timeFrame: 12 weeks (change from baseline)
measure: Foot and Ankle Ability Measure (FAAM)
timeFrame: 26 weeks (change from baseline)
measure: EQ-5D-5L
timeFrame: 6 weeks (change from baseline)
measure: EQ-5D-5L
timeFrame: 12 weeks (change from baseline)
measure: EQ-5D-5L
timeFrame: 26 weeks (change from baseline)
measure: EQ-5D-VAS
timeFrame: 6 weeks (change from baseline)
measure: EQ-5D-VAS
timeFrame: 12 weeks (change from baseline)
measure: EQ-5D-VAS
timeFrame: 26 weeks (change from baseline)
measure: Pain Catastrophizing Scale (PCS)
timeFrame: 6 weeks (change from baseline)
measure: Pain Catastrophizing Scale (PCS)
timeFrame: 12 weeks (change from baseline)
measure: Pain Catastrophizing Scale (PCS)
timeFrame: 26 weeks (change from baseline)
measure: Patient perceptions of team effectiveness (Patient-PTE)
timeFrame: 0 week (post initial consultation)
measure: modified validated version of the 9-item visit-specific satisfaction questionnaire (VSQ-9)
timeFrame: 0 week (post initial consultation)
measure: Modified MedRisk
timeFrame: 12 weeks
measure: Modified MedRisk
timeFrame: 26 weeks
measure: Provider perceptions of team effectiveness (Prodiver-PTE)
timeFrame: Through study completion (once)
measure: Waiting time
timeFrame: Pre-intervention
measure: Adverse events
timeFrame: 12 weeks
measure: Adverse events
timeFrame: 26 weeks
measure: Treatment and compliance
timeFrame: 6 weeks
measure: Treatment and compliance
timeFrame: 12 weeks
measure: Treatment and compliance
timeFrame: 26 weeks
Other outcomes:
Locations:
city: Montréal
country: Canada
facility: Centre de recherche de l'Hôpital Maisonneuve-Rosemont
state: Quebec
Study officials:
References: